Table 1.
Gene-set enrichment analysis of hallmark of cancer enrichment pathways in response to SK1 KD in breast cancer cells.
| Description | Enrichment score | p-value |
|---|---|---|
| HALLMARK_E2F_TARGETS | –0.58603 | 0.001923 |
| HALLMARK_G2M_CHECKPOINT | –0.45283 | 0.001905 |
| HALLMARK_MYC_TARGETS_V1 | –0.40462 | 0.001923 |
| HALLMARK_UV_RESPONSE_UP -0.32927 | 0.012121 | |
| HALLMARK_INFLAMMATORY_ RESPONSE | 0.285129 | 0.026971 |
| HALLMARK_KRAS_SIGNALING_UP | 0.287628 | 0.024896 |
| HALLMARK_IL2_STAT5_SIGNALING | 0.296696 | 0.010526 |
| HALLMARK_APOPTOSIS | 0.300881 | 0.026 |
| HALLMARK_GLYCOLYSIS | 0.30635 | 0.004149 |
| HALLMARK_TNFA_SIGNALING_VIA_ NFKB | 0.314365 | 0.004211 |
| HALLMARK_COMPLEMENT | 0.32964 | 0.004211 |
| HALLMARK_APICAL_JUNCTION | 0.340443 | 0.002075 |
| HALLMARK_MYOGENESIS | 0.34409 | 0.002105 |
| HALLMARK_P53_PATHWAY | 0.354588 | 0.002096 |
| HALLMARK_HYPOXIA | 0.355858 | 0.002105 |
| HALLMARK_FATTY_ACID_ METABOLISM | 0.373058 | 0.003984 |
| HALLMARK_XENOBIOTIC_ METABOLISM | 0.374965 | 0.002075 |
| HALLMARK_ADIPOGENESIS | 0.381432 | 0.002105 |
| HALLMARK_COAGULATION | 0.404393 | 0.001996 |
| HALLMARK_INTERFERON_GAMMA_ RESPONSE | 0.4096 | 0.00211 |
| HALLMARK_EPITHELIAL_ MESENCHYMAL_TRANSITION | 0.414758 | 0.002105 |
| HALLMARK_UV_RESPONSE_DN | 0.437977 | 0.001976 |